Mirador Capital Partners’s Processa Pharmaceuticals PCSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-976	Closed	-$4.88K	–	196
2023 Q3	$4.88K	Buy	976 +38	+4%	+$190	﹤0.01%	185
2023 Q2	$9.33K	Sell	938 -85	-8%	-$846	﹤0.01%	189
2023 Q1	$10.2K	Sell	1,023 -41	-4%	-$410	﹤0.01%	188
2022 Q4	$23.4K	Buy	+1,064	New	+$23.4K	0.01%	190